Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Pandemic and the PCMR.

Pigment cell & melanoma research

Setaluri V.
PMID: 32483886
Pigment Cell Melanoma Res. 2020 Jul;33(4):526. doi: 10.1111/pcmr.12901.

No abstract available.

Cite
Setaluri V. Pandemic and the PCMR. Pigment Cell Melanoma Res. 2020;33(4):526doi: 10.1111/pcmr.12901.
Setaluri, V. (2020). Pandemic and the PCMR. Pigment cell & melanoma research, 33(4), 526. https://doi.org/10.1111/pcmr.12901
Setaluri, Vijayasaradhi. "Pandemic and the PCMR." Pigment cell & melanoma research vol. 33,4 (2020): 526. doi: https://doi.org/10.1111/pcmr.12901
Setaluri V. Pandemic and the PCMR. Pigment Cell Melanoma Res. 2020 Jul;33(4):526. doi: 10.1111/pcmr.12901. PMID: 32483886.
Copy Download .nbib Format: NLM
Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics.

SLAS technology

Zhu N, Wong PK.
PMID: 32833548
SLAS Technol. 2020 Dec;25(6):513-521. doi: 10.1177/2472630320953798. Epub 2020 Aug 24.

The emergence of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens the health of the global population and challenges our preparedness for pandemic threats. Previous outbreaks of coronaviruses and other viruses have suggested...

Cite
Zhu N, Wong PK. Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics. SLAS Technol. 2020;25(6):513-521doi: 10.1177/2472630320953798.
Zhu, N., & Wong, P. K. (2020). Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics. SLAS technology, 25(6), 513-521. https://doi.org/10.1177/2472630320953798
Zhu, Ninghao, and Wong, Pak Kin. "Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics." SLAS technology vol. 25,6 (2020): 513-521. doi: https://doi.org/10.1177/2472630320953798
Zhu N, Wong PK. Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics. SLAS Technol. 2020 Dec;25(6):513-521. doi: 10.1177/2472630320953798. Epub 2020 Aug 24. PMID: 32833548.
Copy Download .nbib Format: NLM
Host genetics and infectious disease: new tools, insights and translational opportunities.

Nature reviews. Genetics

Kwok AJ, Mentzer A, Knight JC.
PMID: 33277640
Nat Rev Genet. 2021 Mar;22(3):137-153. doi: 10.1038/s41576-020-00297-6. Epub 2020 Dec 04.

Understanding how human genetics influence infectious disease susceptibility offers the opportunity for new insights into pathogenesis, potential drug targets, risk stratification, response to therapy and vaccination. As new infectious diseases continue to emerge, together with growing levels of antimicrobial...

Cite
Kwok AJ, Mentzer A, Knight JC. Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet. 2020;22(3):137-153doi: 10.1038/s41576-020-00297-6.
Kwok, A. J., Mentzer, A., & Knight, J. C. (2021). Host genetics and infectious disease: new tools, insights and translational opportunities. Nature reviews. Genetics, 22(3), 137-153. https://doi.org/10.1038/s41576-020-00297-6
Kwok, Andrew J, et al. "Host genetics and infectious disease: new tools, insights and translational opportunities." Nature reviews. Genetics vol. 22,3 (2021): 137-153. doi: https://doi.org/10.1038/s41576-020-00297-6
Kwok AJ, Mentzer A, Knight JC. Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet. 2021 Mar;22(3):137-153. doi: 10.1038/s41576-020-00297-6. Epub 2020 Dec 04. PMID: 33277640; PMCID: PMC7716795.
Copy Download .nbib Format: NLM
A collaborative effort of China in combating COVID-19.

Global health research and policy

Bangura MS, Gonzalez MJ, Ali NM, Ren R, Qiao Y.
PMID: 33292746
Glob Health Res Policy. 2020 Nov 11;5(1):47. doi: 10.1186/s41256-020-00174-z.

A novel coronavirus (COVID-19) was firstly identified in Wuhan by the end of 2019. China has implemented a series of preventive measures to deter COVID-19 spread and its consequences since the beginning of the epidemic. In China, the expansion...

Cite
Bangura MS, Gonzalez MJ, Ali NM, et al. A collaborative effort of China in combating COVID-19. Glob Health Res Policy. 2020;5(1):47doi: 10.1186/s41256-020-00174-z.
Bangura, M. S., Gonzalez, M. J., Ali, N. M., Ren, R., & Qiao, Y. (2020). A collaborative effort of China in combating COVID-19. Global health research and policy, 5(1), 47. https://doi.org/10.1186/s41256-020-00174-z
Bangura, Mohamed S, et al. "A collaborative effort of China in combating COVID-19." Global health research and policy vol. 5,1 (2020): 47. doi: https://doi.org/10.1186/s41256-020-00174-z
Bangura MS, Gonzalez MJ, Ali NM, Ren R, Qiao Y. A collaborative effort of China in combating COVID-19. Glob Health Res Policy. 2020 Nov 11;5(1):47. doi: 10.1186/s41256-020-00174-z. PMID: 33292746; PMCID: PMC7655907.
Copy Download .nbib Format: NLM
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.

Biochimie

Muralidar S, Ambi SV, Sekaran S, Krishnan UM.
PMID: 32971147
Biochimie. 2020 Dec;179:85-100. doi: 10.1016/j.biochi.2020.09.018. Epub 2020 Sep 22.

An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the globe causing serious concerns. The coronavirus disease 2019 (COVID-19) is declared as...

Cite
Muralidar S, Ambi SV, Sekaran S, et al. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85-100doi: 10.1016/j.biochi.2020.09.018.
Muralidar, S., Ambi, S. V., Sekaran, S., & Krishnan, U. M. (2020). The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie, 17985-100. https://doi.org/10.1016/j.biochi.2020.09.018
Muralidar, Shibi, et al. "The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2." Biochimie vol. 179 (2020): 85-100. doi: https://doi.org/10.1016/j.biochi.2020.09.018
Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020 Dec;179:85-100. doi: 10.1016/j.biochi.2020.09.018. Epub 2020 Sep 22. PMID: 32971147; PMCID: PMC7505773.
Copy Download .nbib Format: NLM
What factors drive the satisfaction of citizens with governments' responses to COVID-19?.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Chen CWS, Lee S, Dong MC, Taniguchi M.
PMID: 33115678
Int J Infect Dis. 2021 Jan;102:327-331. doi: 10.1016/j.ijid.2020.10.050. Epub 2020 Oct 25.

OBJECTIVES: This research scrutinizes the important factors influencing the satisfaction of citizens concerning their governments' responses to the COVID-19 pandemic based on an open-sourced survey of 14 countries.METHODS: To collect information on public sentiment regarding governments' reactions to COVID-19,...

Cite
Chen CWS, Lee S, Dong MC, et al. What factors drive the satisfaction of citizens with governments' responses to COVID-19?. Int J Infect Dis. 2020;102:327-331doi: 10.1016/j.ijid.2020.10.050.
Chen, C. W. S., Lee, S., Dong, M. C., & Taniguchi, M. (2021). What factors drive the satisfaction of citizens with governments' responses to COVID-19?. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 102327-331. https://doi.org/10.1016/j.ijid.2020.10.050
Chen, Cathy W S, et al. "What factors drive the satisfaction of citizens with governments' responses to COVID-19?." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 102 (2021): 327-331. doi: https://doi.org/10.1016/j.ijid.2020.10.050
Chen CWS, Lee S, Dong MC, Taniguchi M. What factors drive the satisfaction of citizens with governments' responses to COVID-19?. Int J Infect Dis. 2021 Jan;102:327-331. doi: 10.1016/j.ijid.2020.10.050. Epub 2020 Oct 25. PMID: 33115678.
Copy Download .nbib Format: NLM
The effect of heat-treatment on SARS-CoV-2 viability and detection.

Journal of virological methods

Burton J, Love H, Richards K, Burton C, Summers S, Pitman J, Easterbrook L, Davies K, Spencer P, Killip M, Cane P, Bruce C, Roberts ADG.
PMID: 33515663
J Virol Methods. 2021 Apr;290:114087. doi: 10.1016/j.jviromet.2021.114087. Epub 2021 Jan 28.

The development of safe diagnostic protocols for working with SARS-CoV-2 clinical samples at Biosafety Level 2 (BSL2) requires understanding of the effect of heat-treatment on SARS-CoV-2 viability and downstream RT-PCR sensitivity. In this study heating SARS-CoV-2/England/2/2020 to 56 °C...

Cite
Burton J, Love H, Richards K, et al. The effect of heat-treatment on SARS-CoV-2 viability and detection. J Virol Methods. 2021;290:114087doi: 10.1016/j.jviromet.2021.114087.
Burton, J., Love, H., Richards, K., Burton, C., Summers, S., Pitman, J., Easterbrook, L., Davies, K., Spencer, P., Killip, M., Cane, P., Bruce, C., & Roberts, A. D. G. (2021). The effect of heat-treatment on SARS-CoV-2 viability and detection. Journal of virological methods, 290114087. https://doi.org/10.1016/j.jviromet.2021.114087
Burton, Jane, et al. "The effect of heat-treatment on SARS-CoV-2 viability and detection." Journal of virological methods vol. 290 (2021): 114087. doi: https://doi.org/10.1016/j.jviromet.2021.114087
Burton J, Love H, Richards K, Burton C, Summers S, Pitman J, Easterbrook L, Davies K, Spencer P, Killip M, Cane P, Bruce C, Roberts ADG. The effect of heat-treatment on SARS-CoV-2 viability and detection. J Virol Methods. 2021 Apr;290:114087. doi: 10.1016/j.jviromet.2021.114087. Epub 2021 Jan 28. PMID: 33515663; PMCID: PMC7840429.
Copy Download .nbib Format: NLM
What we know and dont know on SARS-CoV-2 and COVID-19.

Medwave

Silva-Ayarza I, Bachelet VC.
PMID: 34213514
Medwave. 2021 May 25;21(4):e8198. doi: 10.5867/medwave.2021.04.8198.

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus discovered in December 2019 in Wuhan, China, has had an enormous impact on public health worldwide due to its rapid spread and pandemic behavior, challenges in its control and mitigation,...

Cite
Silva-Ayarza I, Bachelet VC. Lo que sabemos y no sabemos sobre SARS-CoV-2 y COVID-19. What we know and dont know on SARS-CoV-2 and COVID-19. Medwave. 2021;21(4):e8198doi: 10.5867/medwave.2021.04.8198.
Silva-Ayarza, I., & Bachelet, V. C. (2021). Lo que sabemos y no sabemos sobre SARS-CoV-2 y COVID-19. What we know and dont know on SARS-CoV-2 and COVID-19. Medwave, 21(4), e8198. https://doi.org/10.5867/medwave.2021.04.8198
Silva-Ayarza, Ignacio, and Bachelet, Vivienne C. "Lo que sabemos y no sabemos sobre SARS-CoV-2 y COVID-19." What we know and dont know on SARS-CoV-2 and COVID-19. Medwave vol. 21,4 (2021): e8198. doi: https://doi.org/10.5867/medwave.2021.04.8198
Silva-Ayarza I, Bachelet VC. Lo que sabemos y no sabemos sobre SARS-CoV-2 y COVID-19. What we know and dont know on SARS-CoV-2 and COVID-19. Medwave. 2021 May 25;21(4):e8198. doi: 10.5867/medwave.2021.04.8198. Spanish. PMID: 34213514.
Copy Download .nbib Format: NLM
Covid-19 and the power of rules.

History and philosophy of the life sciences

Brady M.
PMID: 33502620
Hist Philos Life Sci. 2021 Jan 27;43(1):11. doi: 10.1007/s40656-021-00368-9.

This article discusses the role of human-created rules in our collective adapting to Covid-19 and our survival in its wake. Rules that make sense become institutionalised and play a dual role in our response to the pandemic: they provide...

Cite
Brady M. Covid-19 and the power of rules. Hist Philos Life Sci. 2021;43(1):11doi: 10.1007/s40656-021-00368-9.
Brady, M. (2021). Covid-19 and the power of rules. History and philosophy of the life sciences, 43(1), 11. https://doi.org/10.1007/s40656-021-00368-9
Brady, Malcolm. "Covid-19 and the power of rules." History and philosophy of the life sciences vol. 43,1 (2021): 11. doi: https://doi.org/10.1007/s40656-021-00368-9
Brady M. Covid-19 and the power of rules. Hist Philos Life Sci. 2021 Jan 27;43(1):11. doi: 10.1007/s40656-021-00368-9. PMID: 33502620; PMCID: PMC7839284.
Copy Download .nbib Format: NLM
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies.

Signal transduction and targeted therapy

Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL.
PMID: 34446699
Signal Transduct Target Ther. 2021 Aug 26;6(1):317. doi: 10.1038/s41392-021-00733-x.

Owing to the limitations of the present efforts on drug discovery against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the biological regulation mechanisms underlying COVID-19, alternative or novel therapeutic targets for COVID-19...

Cite
Zhou YW, Xie Y, Tang LS, et al. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther. 2021;6(1):317doi: 10.1038/s41392-021-00733-x.
Zhou, Y. W., Xie, Y., Tang, L. S., Pu, D., Zhu, Y. J., Liu, J. Y., & Ma, X. L. (2021). Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal transduction and targeted therapy, 6(1), 317. https://doi.org/10.1038/s41392-021-00733-x
Zhou, Yu-Wen, et al. "Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies." Signal transduction and targeted therapy vol. 6,1 (2021): 317. doi: https://doi.org/10.1038/s41392-021-00733-x
Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther. 2021 Aug 26;6(1):317. doi: 10.1038/s41392-021-00733-x. PMID: 34446699; PMCID: PMC8390046.
Copy Download .nbib Format: NLM
The Strength of Curiosity and Purpose.

Cell

[No authors listed]
PMID: 33186525
Cell. 2020 Nov 12;183(4):839-840. doi: 10.1016/j.cell.2020.10.031.

No abstract available.

Cite
The Strength of Curiosity and Purpose. Cell. 2020;183(4):839-840doi: 10.1016/j.cell.2020.10.031.
(2020). The Strength of Curiosity and Purpose. Cell, 183(4), 839-840. https://doi.org/10.1016/j.cell.2020.10.031
"The Strength of Curiosity and Purpose." Cell vol. 183,4 (2020): 839-840. doi: https://doi.org/10.1016/j.cell.2020.10.031
The Strength of Curiosity and Purpose. Cell. 2020 Nov 12;183(4):839-840. doi: 10.1016/j.cell.2020.10.031. PMID: 33186525.
Copy Download .nbib Format: NLM
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Signal transduction and targeted therapy

Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F.
PMID: 34117216
Signal Transduct Target Ther. 2021 Jun 11;6(1):233. doi: 10.1038/s41392-021-00653-w.

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback for global economy and health. SARS-CoV-2 has an exceptionally high level of transmissibility and extremely broad...

Cite
Zhang Q, Xiang R, Huo S, et al. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther. 2021;6(1):233doi: 10.1038/s41392-021-00653-w.
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021). Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal transduction and targeted therapy, 6(1), 233. https://doi.org/10.1038/s41392-021-00653-w
Zhang, Qianqian, et al. "Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy." Signal transduction and targeted therapy vol. 6,1 (2021): 233. doi: https://doi.org/10.1038/s41392-021-00653-w
Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther. 2021 Jun 11;6(1):233. doi: 10.1038/s41392-021-00653-w. PMID: 34117216; PMCID: PMC8193598.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries